https://lnkd.in/gCaq7Yce Dr. Russo chats with Jon Atack on his podcast. He dispels myths and talks about recent breakthroughs in the treatment of anxiety and dementia.
CReDO Science LLC
研究服务
A medical cannabis think-and-do tank for better living. The proof is out there!
关于我们
CReDO Science is focused on the development of market disrupting technologies around the Cannabis plant and the endocannabinoid system. To do that however, it is key to identify big solvable problems and conduct the preclinical and clinical research necessary to bring these products safely to market. Our goal is not only to bring the products to market for which we have initiated the patent process but also to innovate new solutions to big problems independently and collaboratively in the greatest areas of unmet need including consulting with other companies on how to make their cannabis products safer and better.
- 网站
-
https://credo-science.com/
CReDO Science LLC的外部链接
- 所属行业
- 研究服务
- 规模
- 2-10 人
- 总部
- Austin
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
获取路线
US，Austin
CReDO Science LLC员工
动态
-
Golden Eagle Partners (GEP) Global Interactive Webinar with Ethan Russo, MD David W. Traylor and the GEP (https://lnkd.in/giEaftZe) team was excited today to continue our Global Interactive Webinars (GIW) with Ethan Russo, MD. Below is the time map, link and password to the Zoom webinar. I hope you enjoy it. We found it to be a very interesting conversation. Best, The GEP team Link to Recording You can access the recording below: https://lnkd.in/gKiBzeCz Passcode: +q0hdApL Time Map 0:00 – Introduction to GEP and David Traylor 2:00 – Ethan Russo, MD introduction 2:45 – Comparing the evolution of biotechnology and Cannabis 4:00 – The Endocannabinoid System 5:15 – GW Pharma experience 7:10 – Lessons learned from GW 9:00 – Ethan’s crowning achievement 10:30 – Other interesting cannabinoids 12:15 – Where are we going with cannabinoids and form factors? 13:45 – Expectations for Cannabis innovation in the near-term 15:45 – Molecules, Indications and the Human side 16:45 – Beverages and other form factors 18:15 – Does Cannabis fit with the pharma model? 20:45 – Generating data and debunking the stigma 22:00 – Potential words of wisdom for psychedelics learned from Cannabis? 23:00 – Personality trait for success?
-
Dr. Ethan Russo will be participating this Wednesday November 13th at 8:00 PT/9:00 MT/11:00 ET/17:00 CEST in the next installment of Golden Eagle Partners Global Interactive Webinars.?Dr. Russo will be telling his story with David W. Traylor and @Matt Daughtery!? ? The GEP (https://lnkd.in/giEaftZe) Global Webinar Series is meant to facilitate the dissemination of knowledge and wisdom from some of the most well-known leaders in the global Cannabis and Psychedelic sectors.?? ? Join this informative and succinct conversation! Register in advance for this webinar: https://lnkd.in/guVGuYHu
Golden Eagle Partners I Leading Global Investment Bank for the Cannabis and Psychopharmacology Sectors
https://www.goldeneaglepartners.com
-
For their special first episode of the Subsistence Crop podcast, Cal Poly Humboldt Cannabis Studies students interviewed Dr. Ethan Russo about his past cannabis use, the ongoing medicinal significance of cannabis use around the world, specific projects he is working on now, and his aspirations for the future of the cannabis industry. https://lnkd.in/gH3EvShk
S1E1: Dr. Ethan Russo, Cannabis and Terpenoid Researcher
https://cannabisstudieslab.com
-
Dr. Ethan Russo will be speaking at #MJBizCon! Make plans to hear him in Vegas this Dec 3-6. Get your ticket today! Here's a 20% off promotion code: MIGL24SPK.?See you there! https://lnkd.in/gSjQbw2t
-
-
Our latest article is a response to a serious misconception recently published in the American Gastroenterology Association’s Clinical Practice Update, which incorrectly lumps cannabinoid hyperemesis syndrome (CHS) with cyclic vomiting syndrome (CVS).?It also addresses conspiracy theories about the role of pesticide and neem contaminants as the cause of CHS.?We hope this article will help licensed medical professionals improve diagnosis, treatment and CHS patient outcomes.
-
Dr. Ethan Russo will be speaking at #MJBizCon! Learn about the exciting, emerging cannabis research in Vegas this Dec 3-6. Get your ticket today! Here's a 20% off promotion code: MIGL24SPK.?See you there! https://lnkd.in/gSjQbw2t
-
-
https://lnkd.in/g9qTD8jD Dr. Ethan Russo joins the Labyrinths with Amanda Knox discussing "The Mind at Large". In this rare in-person interview, Ethan Russo discusses his odyssey from a mainstream neurology practice into ethnobotanical research, his sabbatical with the Machiguenga/Matsigenka tribe in Parque Nacional del Manu in Peru, and his subsequent plunge into psychedelic and cannabis research. This is a deeply personal and in-depth interchange on many current and controversial topics in these fields.?
?Labyrinths with Amanda Knox: #98 - The Mind at Large (Ethan Russo) on Apple Podcasts
podcasts.apple.com
-
Calling all Texas physicians and others interested in cannabis-based-medicine! Join us at the Texas Cannabis Policy Conference in College Station September 12-14. We look forward to seeing you there.
Very excited to welcome speaker Dr. Ethan Russo, renowned cannabis researcher to the conference! Ethan Russo, MD, a leading neurologist and cannabinoid researcher, offers a wealth of knowledge on the pharmacology and therapeutic applications of cannabinoids. Dr. Russo is CEO of CReDO Science, CMO of Andira Pharmaceuticals, and Medical Advisor at Canurta, Inc. He has participated in over 20 botanical cannabis pharmaceutical clinical trials and written more than 70 peer-reviewed journal articles. He was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) and Medical Director of PHYTECS, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system. Impressively, he served as Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex? for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex? for intractable epilepsy. Don't miss this opportunity to hear from Dr. Ethan Russo and other leading experts at the Texas Cannabis Policy Conference – reserve your spot today!
-